Surgery Partners Inc
NASDAQ:SGRY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.61
35.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Surgery Partners Inc
Wall Street
Price Targets
SGRY Price Targets Summary
Surgery Partners Inc
According to Wall Street analysts, the average 1-year price target for
SGRY
is 37.33 USD
with a low forecast of 31.31 USD and a high forecast of 52.5 USD.
SGRY Last Price Targets
Surgery Partners Inc
The latest public price target was made on Nov 13, 2024 by
Brian Tanquilut
from
Jefferies
,
who expects
SGRY
stock to
rise by 89%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Brian Tanquilut
Jefferies
|
40
USD
Upside 89% |
1 month ago
Nov 13, 2024
|
Surgery Partners (SGRY) PT Lowered to $40 at Jefferies
StreetInsider
|
Andrew Mok
Barclays
|
31
USD
Upside 46% |
1 month ago
Nov 13, 2024
|
Surgery Partners (SGRY) PT Lowered to $31 at Barclays
StreetInsider
|
AJ Rice
UBS
|
38
USD
Upside 79% |
2 months ago
Oct 14, 2024
|
UBS Starts Surgery Partners (SGRY) at Buy
StreetInsider
|
Tao Qiu
Macquarie
|
31
USD
Upside 46% |
5 months ago
Jun 28, 2024
|
Macquarie Starts Surgery Partners (SGRY) at Outperform
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SGRY's stock price target?
Price Target
37.33
USD
According to Wall Street analysts, the average 1-year price target for
SGRY
is 37.33 USD
with a low forecast of 31.31 USD and a high forecast of 52.5 USD.
What is Surgery Partners Inc's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Surgery Partners Inc's revenue is
14%.
The projected
CAGR
for the next 4 years is
11%.
What is Surgery Partners Inc's Operating Income forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Surgery Partners Inc's operating income is
11%.
The projected
CAGR
for the next 3 years is
5%.
You don't have any saved screeners yet
